Biomedical subjects
L I Smirnova
Publications and source records attributed to L I Smirnova.
[Stenocardia of effort].
Explore the source record for details and available documents.
[The prevention and treatment of enteritis].
Explore the source record for details and available documents.
[Anti-arrhythmia agents].
Explore the source record for details and available documents.
[Pericarditis. Liver cirrhosis].
Explore the source record for details and available documents.
[Climacteric cardioneurosis].
Explore the source record for details and available documents.
[Indicators of lipid and carbohydrate metabolism in uncomplicated pregnancy].
Explore the source record for details and available documents.
[Use of the peptide hormone melanostatin and its analogs for the synthesis of new antitumor compounds].
A hypothalamic hormone--melanostatin H-L-Pro-L-Leu-NH2- and its 9 analogs were synthesized and their antitumor properties studied. Melanostatin caused a 52-72% inhibition of tumor growth (p less than 0.05) in mice bearing adenocarcinoma of the mammary gland Ca-755, cervical carcinoma CC-5 and melanoma B-16. Non-cytotoxic analogs containing D-leucine or L-lysine showed low activity. Among analogs containing sarcolysine stereomers, chlorphenacyl or chlorambucil, derivatives with L-sarcolysin exerted a high antitumor effect on Ca-755, CC-5, Lewis lung carcinoma, lymphoid leukemia L-1210, sarcoma-37, melanoma B-16 and S-91 (80-99% inhibition of tumor growth, p less than 0.05). L-sarcolysin alone had a higher effect on S-91 only (p less than 0.05). Antitumor effect of melanostatin is due to its amino acid sequences. Melanostatin analogs modified by L-phenylalanine retain their antitumor properties.
[The action of hypothalamic hormone on athymic mice with transplantable strains of human tumors].
The sensitivity of human melanoma and lung cancer strains transplanted to nude mice to the synthetic hormone of hypothalamus--melanostatin has been defined. Correlation has been noted between the rate of melanoma growth inhibition, decrease in the rate of Na-fluorescent accumulation in the tumor and the tendency towards depression of the activity of energetic metabolism enzymes (SDH and alpha-GPDH) in the treated tumors as compared to control. Moderate lymphopenia and absence of effect on the same enzymes of the lymphocytes was also observed. Fluorescent probes can be used in the estimation of the drug action on the tumor and organs.
[Replacement of blood loss during scheduled cesarean section].
Explore the source record for details and available documents.
[Auricular fibrillation].
Explore the source record for details and available documents.
[Acute rheumatism, chorea minor].
Explore the source record for details and available documents.
[Diagnostic value of cytochemical studies of blood leukocytes in myocardial infarct].
Explore the source record for details and available documents.
[Rheumatic diseases of the nervous system].
Explore the source record for details and available documents.